LY2484595;Evacetrapib;cas:1186486-62-3
|
Evacetrapib was a drug under development by Eli Lilly & Company (investigational name LY2484595) that inhibits cholesterylester transfer protein (CETP), which transfers and thereby increases high-density lipoprotein and lowers low-density lipoprotein (CETP......
rechem-china.co.ltd
|
Submit your “eli lilly insulin” inquiry in a minute :
